Earlier this month, Trump announced that his administration had reached agreements with the manufacturers of Wegovy and Zepbound to reduce the prices of the drugs for Medicaid, Medicare and consumers buying the drugs directly, But its unclear whether the deals will reduce costs for states
For example, the LEADER trial showed this benefit for liraglutide, and the SUSTAIN-6 trial demonstrated similar outcomes for semaglutide in people with type 2 diabetes and high cardiovascular risk
Heres what the study found: Body weight change
Additionally, some individuals may experience dizziness, fatigue, headaches, or stomach discomfort
120, Lane 572, Bibo Rd, Zhangjiang Hi-Tech Park, Pudong, Shanghai 201203, P.R